News Roundup: March 13 to March 17


Your weekly roundup of the latest news from Drug Topics®.

Novo Nordisk To Cut Insulin Prices Up To 75%

According to a company press release, the price reductions will go into effect at the start of 2024.

Read More

US District Judge Hearing Arguments to Potentially Halt Distribution of Abortion Pill Mifepristone

The decision could potentially limit abortion access for people all around the United States.

Read More

FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine As Booster Dose For Young Children

A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19.

Read More

FDA Grants De Novo Approval to Non-Invasive Tinnitus Treatment Device

The product, called Lenire, uses bimodal stimulation and will be available in April 2023.

Read More

Nasal Spray For Migraines Gets FDA Approval

The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting.

Read More

Related Videos
© 2024 MJH Life Sciences

All rights reserved.